Journal
FITOTERAPIA
Volume 82, Issue 8, Pages 1313-1317Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.fitote.2011.09.001
Keywords
Microbial transformation; Ginsenoside-Rg(1); Absidia coerulea AS 3.2462; Dehydrogenation; Hydroxylation; Tumor MDR reversal activity
Categories
Funding
- National Science & Technology Major Project 'Key New Drug Creation and Manufacturing', China [2009ZX09301-003-4-1]
- Program for New Century Excellent Talents in University [NCET-06-0155]
Ask authors/readers for more resources
Biotransformation of ginsenoside-Rg(1) (1) by the fungus Absidia coerulea AS 3.2462 yielded five metabolites (2-6). On the basis of spectroscopic data analyses, the metabolites were identified as ginsenoside-F-1 (2), 6 alpha,12 beta-dihydroxydammar-3-one-20(S)-O-beta-D-glucopyranoside (3), 3-oxo-20(S)-protopanaxatriol (4), 3-oxo-7 beta-hydroxy-20(S)-protopanaxatriol (5), and 3-oxo-7 beta,15 alpha-dihydroxy-20(S)-protopanaxatriol (6), respectively. Among them, 5 and 6 are new compounds. These results indicated that Absidia coerulea AS 3.2462 could catalyze the specific C-3 dehydrogenation of derivatives of ginsenoside-Rg(1), as well as hydroxylation at the 7 beta and 15 alpha positions. Metabolites 2,4 and 5 exhibited moderate reversal activity towards A549/taxol MDR tumor cells in vitro. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available